Detailed Information on Publication Record
1997
Antigen Presentation by Common Variable Immunodeficiency (CVID) B Cells and Monocytes is Unimpaired
THON, Vojtěch, H. EGGENBAUER, HM. WOLF, MB. FISCHER, J. LITZMAN et. al.Basic information
Original name
Antigen Presentation by Common Variable Immunodeficiency (CVID) B Cells and Monocytes is Unimpaired
Name in Czech
Antigenní prezentace B lymfocytů a monocytů není u běžné variabilní imunodeficience (CVID) oslabena
Authors
THON, Vojtěch (203 Czech Republic, guarantor), H. EGGENBAUER (40 Austria), HM. WOLF (40 Austria), MB. FISCHER (40 Austria), J. LITZMAN (203 Czech Republic) and J. LOKAJ (203 Czech Republic)
Edition
Clin.Exp.Immunol. 1997, 0009-9104
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30102 Immunology
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.506
RIV identification code
RIV/00216224:14110/97:00030213
Organization unit
Faculty of Medicine
UT WoS
A1997WR92700001
Keywords (in Czech)
CVID
Keywords in English
common variable immunodeficiency; antigen presentation; B cells; monocytes
Tags
International impact, Reviewed
Změněno: 26/6/2009 00:16, prof. MUDr. Vojtěch Thon, Ph.D.
V originále
CVID is a primary immunodeficiency syndrome comprising a heterogeneous group of patients with hypogammaglobulinaemia and defective formation of specific antibodies. Previous studies demonstrated defective T cell responsiveness to antigen in a major subgroup of patients. In the present study we investigated the capacity of peripheral blood monocytes and Epstein-Barr virus (EBV)-transformed B cell lines from seven patients with CVID, including two patients expressing an extended MHC haplotype described to be associated with CVID, to present antigen (Tet. Tox.) to CD4(+) antigen-specific T cell lines from healthy controls. The results presented show an unimpaired capacity of peripheral blood monocytes to present antigen in all patients studied. In addition, the present study demonstrates for the first time that CVID B cells function normally as antigen-presenting cells (APC). These findings indicate that expression of a certain MHC phenotype in CVID is not associated with a defect in the presentation of recall antigen by monocytes and B cells. Based on these studies, uptake, processing and re-expression of recall antigen in association with MHC class II molecules on the APC surface are functional and there is no indication far structural abnormalities of the MHC class II molecules expressed by the patients studied that could be essential for their function in antigen binding and presentation.
In Czech
Antigenní prezentace B lymfocytů a monocytů není u běžné variabilní imunodeficience (CVID) oslabena.